✓ Enriched with full company details from live data.
IndustryResearch
Employees101-250
HeadquartersSan Diego, California, United States
Funding stageOther
Total funding$717.2M
LinkedIn followers3.3K
Est. revenue$4.1M
Ambrx (Nasdaq: AMAM) is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. Ambr
Technology stack
Click any tool to see other companies using it.
Barracuda NetworksBugHerdCloudFlare HostingGoogle AnalyticsGoogle Tag ManagerGravity FormsMedia Temple SSLMobile FriendlyNew RelicOutlookRemoteSalesforceTypekitVimeoWordPress.orgreCAPTCHA
🔥 90 people from Ambrx are searchable on evyAI — names, titles, and unlockable contact info.
Also appears in these lists
- Top 100 Companies Using BugHerd — 8,305 companies
- Top 100 Research in the United States — 29,901 companies
- Top 100 Companies Using Media Temple — 8,325 companies